Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A drug use evaluation of bedtime sedation in geriatric patients.

The Canadian journal of hospital pharmacy·1994
Same author

Village production of West African dwarf goats and sheep in Nigeria.

Tropical animal health and production·1985
Same journal

Creutzfeld-Jakob disease: what we know.

Leadership in health services = Leadership dans les services de sante·1996
Same journal

Creutzfeld-Jakob disease: the Grace General Hospital experience.

Leadership in health services = Leadership dans les services de sante·1996
Same journal

Suggestions for improving AIDS treatment in hospitals.

Leadership in health services = Leadership dans les services de sante·1996
Same journal

Reform of the New Zealand healthcare system.

Leadership in health services = Leadership dans les services de sante·1996
Same journal

In transition: human resource management in Atlantic Canadian hospitals.

Leadership in health services = Leadership dans les services de sante·1996
Same journal

Emergency room services in rural hospitals.

Leadership in health services = Leadership dans les services de sante·1996
See all related articles

Related Experiment Video

Updated: May 23, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Drug utilization: a regional approach.

S D Mack1, J W Demsey

  • 1Formulary/Drug Utilization Project, Ottawa Valley Drug Information Services.

Leadership in Health Services = Leadership Dans Les Services De Sante
|December 9, 1994
PubMed
Summary
This summary is machine-generated.

This study details a regional drug utilization evaluation across 21 Ontario hospitals to improve medication use and patient outcomes. The project identified key areas for enhancing drug efficacy and cost-efficiency in healthcare.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Related Experiment Videos

Last Updated: May 23, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Area of Science:

  • Health Services Research
  • Pharmacoeconomics
  • Clinical Pharmacy

Background:

  • Healthcare systems face challenges in optimizing drug utilization.
  • Regional collaboration is essential for improving medication management.
  • Evaluating drug use impacts patient outcomes and cost-efficiency.

Purpose of the Study:

  • To develop and implement a regional drug utilization evaluation process.
  • To identify opportunities for improving drug use, patient outcomes, and cost-efficiency.
  • To discuss challenges and considerations in establishing such a regional program.

Main Methods:

  • A two-year Hospital Incentive Fund grant supported the initiative.
  • A regional drug utilization evaluation was conducted across 21 Ontario hospitals.
  • The process involved analyzing drug use patterns and their impact.

Main Results:

  • A framework for a regional drug evaluation process was successfully developed.
  • Specific areas for improvement in drug utilization were identified.
  • Potential enhancements for patient outcomes and cost savings were highlighted.

Conclusions:

  • Regional drug utilization evaluations are feasible and beneficial.
  • Continuous assessment is crucial for optimizing medication management.
  • The study provides insights for developing similar regional healthcare initiatives.